An experimental study of dendritic cells transfected with cancer stem-like cells RNA against 9L brain tumors

Cancer Biology and Therapy

Volumn 11, Issue 11, 2011, Pages 974-980

  Xiao, Zong Yu ^a,b,c   Tang, Hao ^a,b,c   Xu, Zhi Min ^a,b,c   Yan, Zhong Jie ^a,b,c   Li, Peng ^a,b   Cai, Ying Qian ^a,b   Jiang, Xiao Dan ^a,b   Xu, Ru Xiang ^a,b,c  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Brain tumor stem cells; Brain tumors; Cancer stem cells; Cancer stem like cells; CD133; Dendritic cells; Glioma; Immunotherapy; RNA

Indexed keywords

CD133 ANTIGEN; NESTIN; RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN TUMOR; CANCER STEM CELL; CANCER SURVIVAL; CONTROLLED STUDY; DENDRITIC CELL; GENETIC TRANSFECTION; GLIOMA; MALE; NONHUMAN; RAT; SURVIVAL TIME; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD; BRAIN NEOPLASMS; CANCER VACCINES; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CULTURE MEDIA; DENDRITIC CELLS; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GLIOSARCOMA; GLYCOPROTEINS; INTERFERON-GAMMA; INTERMEDIATE FILAMENT PROTEINS; KAPLAN-MEIER ESTIMATE; NEOPLASTIC STEM CELLS; NERVE TISSUE PROTEINS; PEPTIDES; RATS; RNA; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79957832643     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.11.11.15705     Document Type: Article

References (37)

1. Bondy ML, Scheurer ME, Malmer B, Barnholtz-Sloan JS, Davis FG, Il'Yasova D, et al. Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 2008; 113:1953-68.
2. Jordan CT, Guzman ML, Noble M. Cancer stem cells. N Engl J Med 2006; 355:1253-61. (Pubitemid 44427449)
3. Ignatova TN, Kukekov VG, Laywell ED, Suslov ON, Vrionis FD, Steindler DA. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 2002; 39:193-206.
4. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63:5821-8. (Pubitemid 37187480)
5. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, et al. Identification of human brain tumour initiating cells. Nature 2004; 432:396-401. (Pubitemid 39551674)
6. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 2004; 64:7011-21. (Pubitemid 39331011)
7. Kondo T, Setoguchi T, Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA 2004; 101:781-6. (Pubitemid 38121035)
8. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006; 444:756-60. (Pubitemid 44949604)
9. + cancer stem cells in glioblastoma. Mol Cancer 2006; 5:67.
10. Eyler CE, Rich JN. Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis. J Clin Oncol 2008; 26:2839-45.
11. Stiles CD, Rowitch DH. Glioma stem cells: a midterm exam. Neuron 2008; 58:832-46. (Pubitemid 351842757)
12. Oliver TG, Wechsler-Reya RJ. Getting at the root and stem of brain tumors. Neuron 2004; 42:885-8. (Pubitemid 38798227)
13. Boczkowski D, Nair SK, Snyder D, Gilboa E. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J Exp Med 1996; 184:465-72. (Pubitemid 26324100)
14. Yu Z, Sun H, Zhang T, Yang T, Long H, Ma B. Specific antitumor effects of tumor vaccine produced by autologous dendritic cells transfected with allogeneic osteosarcoma total RNA through electroporation in rats. Cancer Biol Ther 2009; 8:973-80.
15. Vichchatorn P, Wongkajornsilp A, Petvises S, Tangpradabkul S, Pakakasama S, Hongeng S. Dendritic cells pulsed with total tumor RNA for activation NK-like T cells against glioblastoma multiforme. J Neurooncol 2005; 75:111-8. (Pubitemid 41819712)
16. Zhang W, He L, Yuan Z, Xie Z, Wang J, Hamada H, et al. Enhanced therapeutic efficacy of tumor RNApulsed dendritic cells after genetic modification with lymphotactin. Hum Gene Ther 1999; 10:1151-61. (Pubitemid 29233384)
17. Kalady MF, Onaitis MW, Emani S, Abdul-Wahab Z, Pruitt SK, Tyler DS. Dendritic cells pulsed with pancreatic cancer total tumor RNA generate specific antipancreatic cancer T cells. J Gastrointest Surg 2004; 8:175-81.
18. Minami T, Nakanishi Y, Izumi M, Harada T, Hara N. Enhancement of antigen-presenting capacity and antitumor immunity of dendritic cells pulsed with autologous tumor-derived RNA in mice. J Immunother 2003; 26:420-31. (Pubitemid 37128554)
19. Nair SK, Boczkowski D, Morse M, Cumming RI, Lyerly HK, Gilboa E. Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA. Nat Biotechnol 1998; 16:364-9. (Pubitemid 28164657)
20. Boczkowski D, Nair SK, Nam JH, Lyerly HK, Gilboa E. Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells. Cancer Res 2000; 60:1028-34. (Pubitemid 30129541)
21. Tyagi RK, Mangal S, Garg N, Sharma PK. RNA-based immunotherapy of cancer: role and therapeutic implications of dendritic cells. Expert Rev Anticancer Ther 2009; 9:97-114.
22. Mitchell DA, Nair SK. RNA-transfected dendritic cells in cancer immunotherapy. J Clin Invest 2000; 106:1065-9.
23. Ghods AJ, Irvin D, Liu G, Yuan X, Abdulkadir IR, Tunici P, et al. Spheres isolated from 9L gliosarcoma rat cell line possess chemoresistant and aggressive cancer stem-like cells. Stem Cells 2007; 25:1645-53. (Pubitemid 47121841)
24. Wang J, Sakariassen PO, Tsinkalovsky O, Immervoll H, Boe SO, Svendsen A, et al. CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int J Cancer 2008; 122:761-8.
25. Zheng X, Shen G, Yang X, Liu W. Most C6 cells are cancer stem cells: evidence from clonal and population analyses. Cancer Res 2007; 67:3691-7. (Pubitemid 46762154)
26. Sulman E, Aldape K, Colman H. Brain tumor stem cells. Curr Probl Cancer 2008; 32:124-42. (Pubitemid 351697557)
27. Nair SK, Snyder D, Rouse BT, Gilboa E. Regression of tumors in mice vaccinated with professional antigenpresenting cells pulsed with tumor extracts. Int J Cancer 1997; 70:706-15. (Pubitemid 27158451)
28. Barth RJ, Mule JJ, Spiess PJ, Rosenberg SA. Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes. J Exp Med 1991; 173:647-58.
29. Becker C, Pohla H, Frankenberger B, Schuler T, Assenmacher M, Schendel DJ, et al. Adoptive tumor therapy with T lymphocytes enriched through an IFNgamma capture assay. Nat Med 2001; 7:1159-62. (Pubitemid 33010027)
30. Xu Q, Liu G, Yuan X, Xu M, Wang H, Ji J, et al. Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens. Stem Cells 2009; 27:1734-40.
31. Garcia-Hernandez ML, Gray A, Hubby B, Klinger OJ, Kast WM. Prostate stem cell antigen vaccination induces a long-term protective immune response against prostate cancer in the absence of autoimmunity. Cancer Res 2008; 68:861-9. (Pubitemid 351206764)
32. Pellegatta S, Poliani PL, Corno D, Menghi F, Ghielmetti F, Suarez-Merino B, et al. Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas. Cancer Res 2006; 66:10247-52. (Pubitemid 44799739)
33. + cytolytic T cells. Cancer Res 2009; 69:8886-93.
34. Irvin DK, Jouanneau E, Duvall G, Zhang XX, Zhai Y, Sarayba D, et al. T cells enhance stem-like properties and conditional malignancy in gliomas. PLoS One 2010; 5:e10974.
35. Hatiboglu MA, Wei J, Wu AS, Heimberger AB. Immune therapeutic targeting of glioma cancer stem cells. Target Oncol 2010; 5:217-27.
36. Porgador A, Gilboa E. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J Exp Med 1995; 182:255-60.
37. Ashley DM, Faiola B, Nair S, Hale LP, Bigner DD, Gilboa E. Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors. J Exp Med 1997; 186:1177-82. (Pubitemid 27441162)